PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33667901-0	2021	Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.	Peptides	26-33	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	103-123	
23765660-4	2013	We also describe the measurement of OGT activity by using synthetic peptides as acceptors and radiolabeled UDP-GlcNAc.	Peptides	68-76	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	36-39	
32991074-5	2021	We report linear bisubstrate ether-linked uridine-peptide conjugates as OGT inhibitors having micromolar affinity.	Peptides	50-57	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	72-75	
30657688-4	2019	In this method, the O-GlcNAc moiety on peptides was labeled with UDP-GalNAz followed by copper-free azide-alkyne cycloaddition with a multifunctional reagent bearing a terminal cyclooctyne, a disulfide bridge, and a biotin handle.	Peptides	39-47	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	20-28	
25980911-5	2015	At least 500fmol of O-GlcNAc-modified peptides was selectively isolated from alpha-crystallin tryptic peptides and detected by mass spectrometry.	Peptides	38-46	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	20-28	
21472528-5	2011	Integrating the OScore into the two-stage LC-MS/MS approach detected O-GlcNAc peptides in the low fmol range and at 10-fold better sensitivity than a single data-dependent ETD tandem MS experiment.	Peptides	78-86	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	69-77